Arrhythmias & electrophysiologyRandomised controlled trial

Effect of Renal Denervation and Catheter Ablation vs Catheter Ablation Alone on Atrial Fibrillation Recurrence Among Patients With Paroxysmal Atrial Fibrillation and Hypertension

JAMAPublished

  • Randomised controlled trial
  • investigator-initiated
  • multicentre
  • single-blind
  • 5 referral centres (Russian Federation, Poland, Germany)
  • No formal sham-control renal denervation procedure

Authors' conclusion

Among patients with paroxysmal atrial fibrillation and hypertension, renal denervation added to catheter ablation, compared with catheter ablation alone, significantly increased the likelihood of freedom from atrial fibrillation at 12 months.

Study context

Population
Patients with paroxysmal AF and hypertension despite ≥1 antihypertensive medication, planned for ablation283 [93.7%] completed
Participants
302 patients
Comparison
PVI plus renal denervation vs PVI alone
  • Isolation-onlyn = 148reference
  • Renal denervationn = 154
Primary endpoint
Freedom from AF, atrial flutter or atrial tachycardia
Follow-up
12 months

Primary result

As reported in the abstract

Hazard ratio

0.57

95% CI 0.38–0.85

P = 0.006

Events by treatment group

PVI plus renal denervation vs PVI alone
HR 0.57 (95% CI 0.38–0.85); P = 0.006

Secondary outcomes

OutcomeIsolation-onlyRenal denervationbetween-group difference (mm Hg) (95% CI)P value
Mean SBP, baseline to 12 monthsmean 147 mm Hgmean 135 mm Hg−13 (−15 to −11)P < 0.001
Baseline151 mm Hg150 mm Hg

Prespecified secondary end points

Of 5 prespecified secondary end points, 4 reported and 3 differed between groups

Safety

Procedural complications · within 30 days

Original publication

Effect of Renal Denervation and Catheter Ablation vs Catheter Ablation Alone on Atrial Fibrillation Recurrence Among Patients With Paroxysmal Atrial Fibrillation and Hypertension. JAMA. Published 21 January 2020. doi:10.1001/jama.2019.21187

Summarised from the published abstract; every number is checked against it